Effects of raw red beetroot consumption on metabolic markers and cognitive function in type 2 diabetes patients

被引:26
|
作者
Aliahmadi, Mitra [1 ]
Amiri, Fatemehsadat [1 ]
Bahrami, Leila Sadat [2 ]
Hosseini, Agha Fatemeh [3 ]
Abiri, Behnaz [4 ]
Vafa, Mohammadreza [1 ]
机构
[1] Iran Univ Med Sci, Sch Publ Hlth, Dept Nutr, Tehran, Iran
[2] Mashhad Univ Med Sci, Fac Med, Dept Nutr, Mashhad, Razavi Khorasan, Iran
[3] Iran Univ Med Sci, Sch Publ Hlth, Dept Biostat, Tehran, Iran
[4] Ahvaz Jundishapur Univ Med Sci, Fac Paramed, Dept Nutr, Ahvaz, Iran
关键词
Raw red beetroot; Type; 2; diabetes; Metabolic markers; Cognitive function; DIETARY NITRATE SUPPLEMENTATION; BETA-VULGARIS; BLOOD-PRESSURE; ANTIOXIDANT ACTIVITY; DOUBLE-BLIND; JUICE; MANAGEMENT; BETALAINS; PARAOXONASE; DISEASE;
D O I
10.1007/s40200-021-00798-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study aimed to investigate the effects of raw red beetroot consumption on metabolic markers and cognitive function in type 2 diabetes patients. Methods In a quasi-experimental study, 44 type 2 diabetes patients (57 +/- 4.5 years) consumed raw red beetroot (100 g, daily), for 8 weeks. Metabolic markers including body weight, glucose and lipid profile parameters, inflammatory and oxidative stress markers, paraoxonase-1 activity, hepatic enzymes, blood pressure and cognitive function were measured at the beginning and end of 8 weeks. Results Raw red beetroot consumption resulted in a significant decrease in fasting blood sugar (FBS) levels (-13.53 mg/dL), glycosylated hemoglobin (HbA1c)(-0.34%), apolipoproteinB100 (ApoB100) (-8.25 mg/dl), aspartate aminotransferase (AST) (-1.75 U/L), alanine aminotransferase (ALT) (-3.7 U/L), homocysteine (-7.88 mu mol/l), systolic (-0.73 mmHg) and diastolic blood pressure (-0.34 mmHg), and a significant increase in total antioxidant capacity (TAC) (105 mu mol/L) and cognitive function tests (all P values <0.05). Other variables did not change significantly after the intervention. Conclusions Raw red beetroot consumption for 8 weeks in T2DM patients has beneficial impacts on cognitive function, glucose metabolism and other metabolic markers.
引用
收藏
页码:673 / 682
页数:10
相关论文
共 50 条
  • [41] The Use of Exenatide in Managing Markers of Cardiovascular Risk in Patients with Type 2 Diabetes: A Systematic Review
    Ojo, Omorogieva
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2016, 13 (10)
  • [42] Metabolic effects of Troglitazone in patients with diet-controlled type 2 diabetes
    Robinson, ACJ
    Jeffs, JAR
    Gray, RG
    Bannister, PA
    Mather, H
    Gallagher, JJ
    Robinson, S
    Nattrass, M
    Venkatesan, S
    Halliday, D
    Johnston, DG
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (01) : 29 - 36
  • [43] Effects of exercise training on mitochondrial function in patients with type 2 diabetes
    Larsen, Steen
    Skaaby, Stinna
    Helge, Jorn W.
    Dela, Flemming
    WORLD JOURNAL OF DIABETES, 2014, 5 (04): : 482 - 492
  • [44] Type 2 diabetes, glycaemic traits, structural brain capacity and cognitive function: A Mendelian randomization analysis
    Luo, Manjun
    Sun, Mengting
    Wang, Tingting
    Wei, Jianhui
    Ruan, Xiaorui
    Chen, Kebin
    Ou, Jun
    Chen, Yige
    Qin, Jiabi
    DIABETES OBESITY & METABOLISM, 2024, 26 (09) : 3618 - 3632
  • [45] Burden of Uncontrolled Metabolic Risk Factors and Left Ventricular Structure and Function in Patients With Type 2 Diabetes Mellitus
    Jorgensen, Peter Godsk
    Jensen, Magnus Thorsten
    Biering-Sorensen, Tor
    Mogelvang, Rasmus
    Fritz-Hansen, Thomas
    Vilsboll, Tina
    Rossing, Peter
    Jensen, Jan Skov
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (19):
  • [46] Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver
    Macfarlane, D. P.
    Raubenheimer, P. J.
    Preston, T.
    Gray, C. D.
    Bastin, M. E.
    Marshall, I.
    Iredale, J. P.
    Andrew, R.
    Walker, B. R.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2014, 307 (07): : G760 - G768
  • [47] EVALUATION OF METABOLIC PANEL AND HEPATITIS MARKERS OF TYPE 2 DIABETES MELLITUS PATIENTS
    Mamur, Ahmet
    Kayhan, Mehmet
    Oztas, Dilek
    ACTA MEDICA MEDITERRANEA, 2017, 33 (06): : 1003 - 1006
  • [48] Effects of pioglitazone and glipizide on platelet function in patients with type 2 diabetes
    Xiao, C. -C.
    Ren, A.
    Yang, J.
    Ye, S. -D.
    Xing, X. -N.
    Li, S. -M.
    Chen, C.
    Chen, R. -P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (06) : 963 - 970
  • [49] Relationship between glycemic variability and cognitive function in lacune patients with type 2 diabetes
    Meng, Qi-Zhe
    Wang, Yang
    Li, Bing
    Xi, Zhi
    Wang, Ming
    Xiu, Jia-Qi
    Yang, Xiao-Peng
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (05) : 1019 - 1030
  • [50] Assciation between Cognitive and Social Factors and Metabolic Control Parameters in Patients with Type 2 Diabetes
    Orhan, Berna
    Karabacak, Bilgi Gulseven
    CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2016, 6 (01): : 1 - 8